Lab Manager | Run Your Lab Like a Business
Non-Invasive Cervical Cancer Screening

Non-Invasive Cervical Cancer Screening

HPV-based cervical cancer screening using a Pap smear-free device for urine self-collection


Novosanis is a Belgian-based medical device company, founded on March 12, 2013 as a spin-off company from the University of Antwerp, Belgium. Since 2019, it is a wholly owned subsidiary...

ViewFull Profile.
Learn about ourEditorial Policies.

Cervical cancer can be prevented through vaccination and screening; however, it remains the fourth most common cancer type in women, with over 500,000 cases detected in 2018. Most cases of cervical cancer have been linked to types of high-risk Human Papillomavirus (HPV), a common sexually transmitted infection.

Download the white paper to learn how a new urine-collecting device will give doctors a user-friendly option for cervical cancer screening, from Novosanis.